Table 1. Baseline Characteristics of Study Participants.
| Age (yrs) | 63 ± 9 |
| Male | 32 (78%) |
| BMI (kg/m2) | 29 ± 5 |
| LVEF (%) | 63 ± 12 |
| Angina (CCS) | |
| Class 1 | 11 (27%) |
| Class 2 | 22 (54%) |
| Class 3 | 8 (20%) |
| Diabetes | 13 (32%) |
| Hypertension | 30 (73%) |
| Smoking | |
| Current | 5 (12%) |
| Previous | 21 (51%) |
| Family history CAD | 19 (46%) |
| Cerebrovascular disease | 4 (10%) |
| Previous PCI | 13 (32%) |
| Previous myocardial infarct | 5 (12%) |
| Medications | |
| Aspirin | 33 (80%) |
| Clopidogrel | 18 (44%) |
| Statin | 35 (85%) |
| ACE inhibitor | 22 (54%) |
| Angiotensin receptor blocker | 6 (15%) |
| Beta-blocker | 21 (51%) |
| Calcium channel blocker | 13 (32%) |
| Nitrate | 7 (17%) |
| Coronary disease ≥70% | |
| Left anterior descending | 7 (17%) |
| Circumflex | 12 (29%) |
| Right coronary artery | 13 (32%) |
Values are mean ± SD or n (%). Percentages have been rounded to nearest 1% and therefore might not total 100%. ACE = angiotensin-converting enzyme; BMI = body mass index; CAD = coronary artery disease; CCS = Canadian Cardiovascular Society; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention.